Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, March 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 206 articles:
HTML format


 

Single Articles

  1. DA ROCHA SMM, Dos Santos Cardoso PC, de Oliveira Bahia M, do O Pessoa C, et al
    Effect of the kaurenoic acid on genotoxicity and cell cycle progression in cervical cancer cells lines.
    Toxicol In Vitro. 2019 Feb 26. pii: S0887-2333(18)30847.
    Abstract    



  2. THOMSEN LT, Kjaer SK
    Women with cervical cancer precursor lesions: a high-risk group for human papillomavirus (HPV)-related oropharyngeal cancer?
    Acta Oncol. 2019 Mar 1:1-2. doi: 10.1080/0284186X.2019.1581378.
    Abstract    



  3. LUBOWICKA E, Zbucka-Kretowska M, Sidorkiewicz I, Zajkowska M, et al
    Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC Analysis.
    Pathol Oncol Res. 2019 Feb 28. pii: 10.1007/s12253-019-00626.
    Abstract    

    Abstract available

  4. LINDE DS, Rasch V, Mwaiselage JD, Gammeltoft TM, et al
    Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    BMJ Open. 2019;9:e024011.
    Abstract    

    Abstract available

  5. VASSILAKOS P, Petignat P
    [Organized cervical cancer screening in France: can we still do better?]
    Gynecol Obstet Fertil Senol. 2019 Feb 25. pii: S2468-7189(19)30074.
    Abstract    



  6. CASTELLANO T, Ding K, Moore KN, Landrum LM, et al
    Simple Hysterectomy for Cervical Cancer: Risk Factors for Failed Screening and Deviation From Screening Guidelines.
    J Low Genit Tract Dis. 2019 Feb 26. doi: 10.1097/LGT.0000000000000463.
    Abstract    

    Abstract available

  7. SNOEK BC, Splunter APV, Bleeker MCG, Ruiten MCV, et al
    Cervical cancer detection by DNA methylation analysis in urine.
    Sci Rep. 2019;9:3088.
    Abstract    

    Abstract available

  8. SANCHEZ-SANDOVAL AL, Gomora JC
    Contribution of voltage-gated sodium channel beta-subunits to cervical cancer cells metastatic behavior.
    Cancer Cell Int. 2019;19:35.
    Abstract    

    Abstract available

  9. SHIN SS, Carpenter CL, Ekstrand ML, Wang Q, et al
    Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.
    Int J STD AIDS. 2019 Feb 27:956462419825950. doi: 10.1177/0956462419825950.
    Abstract    

    Abstract available

  10. STONE SC, Rossetti RAM, Alvarez KLF, Carvalho JP, et al
    Lactate secreted by cervical cancer cells modulates macrophage phenotype.
    J Leukoc Biol. 2019 Feb 27. doi: 10.1002/JLB.3A0718.
    Abstract    

    Abstract available

  11. CARVALHO J, Lopes-Nunes J, Lopes AC, Cabral Campello MP, et al
    Aptamer-guided acridine derivatives for cervical cancer.
    Org Biomol Chem. 2019 Feb 27. doi: 10.1039/c9ob00318.
    Abstract    

    Abstract available

  12. KOYUNCU I, Tuluce Y, Slahaddin Qadir H, Durgun M, et al
    Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
    J Enzyme Inhib Med Chem. 2019;34:703-711.
    Abstract    

    Abstract available

  13. GLINIEWICZ A, Zielinska A, Kwiatkowska K, Dudek-Godeau D, et al
    Survival in women diagnosed with breast and cervical cancer in Poland - compared to European countries, based on CONCORD - 3 Programme
    Przegl Epidemiol. 2018;72:499-508.
    Abstract    

    Abstract available

  14. KUNG TH, Gordon JR, Abdullahi A, Barve A, et al
    "My husband says this: If you are alive, you can be someone...": Facilitators and barriers to cervical cancer screening among women living with HIV in India.
    Cancer Causes Control. 2019 Feb 26. pii: 10.1007/s10552-019-01145.
    Abstract    

    Abstract available

  15. LI L, Liu M, Zhang Z, Zhang W, et al
    Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Biol Res. 2019;52:8.
    Abstract    

    Abstract available

  16. PISTA A, Costa C, Saldanha C, Moutinho JAF, et al
    Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies.
    BMC Public Health. 2019;19:235.
    Abstract    

    Abstract available

  17. PIMPLE S, Mishra G
    Global strategies for cervical cancer prevention and screening.
    Minerva Ginecol. 2019 Feb 22. pii: S0026-4784.19.04397.
    Abstract    

    Abstract available

  18. SHYU IL, Hu LY, Chen YJ, Wang PH, et al
    Risk factors for developing depression in women with cervical cancer: a nationwide population-based study in Taiwan.
    Int J Womens Health. 2019;11:135-141.
    Abstract    

    Abstract available

  19. DING X, Jia X, Wang C, Xu J, et al
    Correction to: A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer.
    Cell Death Differ. 2019 Feb 25. pii: 10.1038/s41418-019-0273.
    Abstract    

    Abstract available

  20. THAY S, Goldstein A, Goldstein LS, Govind V, et al
    Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    BMJ Open. 2019;9:e026887.
    Abstract    

    Abstract available

  21. CLARK M, Lee A, Kupets R
    Limitations in Correspondence Programs for Cervical Cancer Screening: Who Are the Women We Are Missing?
    J Obstet Gynaecol Can. 2019 Feb 22. pii: S1701-2163(18)31000.
    Abstract    

    Abstract available

  22. LEE H, Hur S, Jang H, Lee IH, et al
    Cost-Utility of a Two-Dose Human Papillomavirus Vaccination Programme Added to Cervical Cancer Screening Compared with Cervical Cancer Screening Alone in Korea
    Asian Pac J Cancer Prev. 2019;20:425-435.
    Abstract    

    Abstract available

  23. SAENRUEANG T, Promthet S, Kamsa-Ard S, Pengsaa P, et al
    Cervical Cancer in Khon Kaen, Thailand: Analysis of 1990-2014 Incidence Data and Prediction of Future Trends
    Asian Pac J Cancer Prev. 2019;20:369-375.
    Abstract    

    Abstract available

  24. MIRIYALA R, Rai B, Ballari NR, Oinam AS, et al
    Prospective study to quantify the expansion volumes around the involved pelvic lymph nodes for planning Simultaneous Integrated Boost in patients of cervical cancer undergoing pelvic Intensity Modulated Radiotherapy.
    Pract Radiat Oncol. 2019 Feb 22. pii: S1879-8500(19)30054.
    Abstract    

    Abstract available

  25. YUAN P, Liu Z, Qi J, Yang X, et al
    Laparoscopic Radical Hysterectomy with Enclosed Colpotomy and without the Use of Uterine Manipulator for Early-stage Cervical Cancer.
    J Minim Invasive Gynecol. 2019 Feb 22. pii: S1553-4650(19)30100.
    Abstract    

    Abstract available

  26. MATSUO K, Chen L, Mandelbaum RS, Melamed A, et al
    Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally-invasive surgery versus laparotomy.
    Am J Obstet Gynecol. 2019 Feb 22. pii: S0002-9378(19)30390.
    Abstract    

    Abstract available

  27. WOO S, Moon MH, Cho JY, Kim SH, et al
    Diagnostic Performance of MRI for Assessing Parametrial Invasion in Cervical Cancer: A Head-to-Head Comparison between Oblique and True Axial T2-Weighted Images.
    Korean J Radiol. 2019;20:378-384.
    Abstract    

    Abstract available

  28. NANI S, Hassoune S, Benallal M, Kissi D, et al
    Knowledge by physicians concerning cervical cancer and testing: Benimellal province, Morocco.
    East Mediterr Health J. 2019;24:1135-1145.
    Abstract    

    Abstract available

  29. ANNEDE P, Dumas I, Schernberg A, Tailleur A, et al
    Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Brachytherapy. 2019 Feb 20. pii: S1538-4721(18)30628.
    Abstract    

    Abstract available

  30. HERTZUM-LARSEN R, Kjaer SK, Frederiksen K, Thomsen LT, et al
    Participation in cervical cancer screening among immigrants and Danish-born women in Denmark.
    Prev Med. 2019 Feb 20. pii: S0091-7435(19)30062.
    Abstract    

    Abstract available

  31. BRISSON M, Drolet M
    Global elimination of cervical cancer as a public health problem.
    Lancet Oncol. 2019 Feb 19. pii: S1470-2045(19)30072.
    Abstract    



  32. SIMMS KT, Steinberg J, Caruana M, Smith MA, et al
    Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Lancet Oncol. 2019 Feb 19. pii: S1470-2045(18)30836.
    Abstract    

    Abstract available

  33. HORN LC, Hohn AK, Hentschel B, Fischer U, et al
    Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomas.
    J Cancer Res Clin Oncol. 2019;145:457-462.
    Abstract    

    Abstract available

  34. DING L, Feng MJ, Liu CL, Wang L, et al
    [Effect of hnRNP K and its interaction with HPV16 on cervical intraepithelial neoplasia].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:1630-1635.
    Abstract    

    Abstract available

  35. FUDULU A, Albulescu A, Anton G
    Human papillomaviruses' proteins with clinical utility.
    J Immunoassay Immunochem. 2019;40:81-90.
    Abstract    

    Abstract available

  36. LI L, Ding L, Lyu YJ, Wang M, et al
    [Interaction between vaginal micro-environment alterations and HPV16 infection in cervical intraepithelial neoplasia].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:1486-1490.
    Abstract    

    Abstract available

  37. ZHANG K, Zhao Q, Qin S, Fu Y, et al
    Nanodiamonds conjugated upconversion nanoparticles for bio-imaging and drug delivery.
    J Colloid Interface Sci. 2019;537:316-324.
    Abstract    

    Abstract available

  38. TERLAN RJ, Cesar JA
    Non-performance of Pap smears among pregnant women in the Extreme South of Brazil: prevalence and associated factors.
    Cien Saude Colet. 2018;23:3557-3566.
    Abstract    

    Abstract available

  39. HESTER A, Ritzer M, Kuhn C, Schmoeckel E, et al
    The role of EP3-receptor expression in cervical dysplasia.
    J Cancer Res Clin Oncol. 2019;145:313-319.
    Abstract    

    Abstract available

  40. TAGHINEZHAD-S S, Mohseni AH, Keyvani H, Razavilar V, et al
    Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
    Microb Pathog. 2019;126:149-156.
    Abstract    

    Abstract available

  41. RUSSI AE, Bhaumik S, Herzog JJ, Tschoe M, et al
    Impact of an education-centered medical home on quality at a student-volunteer free clinic.
    Med Educ Online. 2018;23:1505401.
    Abstract    

    Abstract available

  42. NUNES RAL, Morale MG, Silva GAF, Villa LL, et al
    Innate immunity and HPV: friends or foes.
    Clinics (Sao Paulo). 2018;73.
    Abstract    

    Abstract available

  43. IVANOVIC J, Mesaros S, Drulovic J
    Successful treatment of paraneoplastic longitudinally extensive transverse myelitis (LETM): A 16-month clinical-spinal MRI follow-up.
    Mult Scler Relat Disord. 2018;26:207-210.
    Abstract    

    Abstract available

  44. YEO C, Fang H, Thilagamangai, Koh SSL, et al
    Factors affecting Pap smear uptake in a maternity hospital: A descriptive cross-sectional study.
    J Adv Nurs. 2018;74:2533-2543.
    Abstract    

    Abstract available

  45. SONG J, Hu Q, Huang J, Ma Z, et al
    Combining tumor size and diffusion-weighted imaging to diagnose normal-sized metastatic pelvic lymph nodes in cervical cancers.
    Acta Radiol. 2019;60:388-395.
    Abstract    

    Abstract available

  46. CHEN Z, Rao J
    Positron Emission Tomography Imaging of Tumor Apoptosis with a Caspase-Sensitive Nano-Aggregation Tracer [(18)F]C-SNAT.
    Methods Mol Biol. 2018;1790:181-195.
    Abstract    

    Abstract available

  47. HSU YY, Wang WM, Fetzer SJ, Cheng YM, et al
    Longitudinal psychosocial adjustment of women to human papillomavirus infection.
    J Adv Nurs. 2018;74:2523-2532.
    Abstract    

    Abstract available

  48. GASHI G, Mahovlic V, Bahtiri E, Kurshumliu F, et al
    Assessment of the association between the frequency of micronucleus and p(16INK4a)/Ki-67 co-expression in patients with cervical intraepithelial lesions.
    Biotech Histochem. 2018;93:496-504.
    Abstract    

    Abstract available

  49. REED G
    Distance.
    Fam Med. 2018;50:385-386.
    Abstract    



  50. SKARE TL, Neppel A, Machoski MCC, Maestri CA, et al
    ANTINUCLEAR ANTIBODIES IN PATIENTS WITH CERVICAL LESIONS AND INVASIVE CERVICAL CANCER.
    Immunol Lett. 2019 Mar 5. pii: S0165-2478(19)30051.
    Abstract    

    Abstract available

  51. ZHANG S, Batur P
    Human papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines.
    Cleve Clin J Med. 2019;86:173-178.
    Abstract    

    Abstract available

  52. DOS SANTOS LN, Castaneda L, de Aguiar SS, Thuler LCS, et al
    Health-related Quality of Life in Women with Cervical Cancer.
    Rev Bras Ginecol Obstet. 2019 Mar 7. doi: 10.1055/s-0039-1683355.
    Abstract    

    Abstract available

  53. MIYOSHI A, Kuritani Y, Kanao S, Naoi H, et al
    Aggressive skeletal muscle metastasis from cervical cancer invading into the spinal canal: A case report.
    Clin Case Rep. 2019;7:361-365.
    Abstract    

    Abstract available

  54. MABUCHI Y, Takiguchi Y, Yahata T, Mizoguchi M, et al
    Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer.
    Mol Clin Oncol. 2019;10:382-386.
    Abstract    

    Abstract available

  55. ROMLI R, Shahabudin S, Saddki N, Mokhtar N, et al
    Cervical cancer and pap smear screening: knowledge, attitude and practice among working women in northern state of Malaysia.
    Med J Malaysia. 2019;74:8-14.
    Abstract    

    Abstract available

  56. CHEN B, Jiao Y, Yaolong F, Li T, et al
    The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.
    Pathol Res Pract. 2019 Feb 27. pii: S0344-0338(18)31776.
    Abstract    

    Abstract available

  57. MATSUO K, Shimada M, Nakamura K, Takei Y, et al
    Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
    Eur J Surg Oncol. 2019 Feb 18. pii: S0748-7983(19)30290.
    Abstract    

    Abstract available

  58. TSAI YL, Yu PC, Nien HH, Sung SY, et al
    Radiation Dose in the Uterine Perforation by Tandem in 3-Dimensional Cervical Cancer Brachytherapy.
    Med Dosim. 2019 Mar 4. pii: S0958-3947(19)30024.
    Abstract    

    Abstract available

  59. KORKUT Y
    Assessment of knowledge, attitudes, and behaviors regarding breast and cervical cancer among women in western Turkey.
    J Int Med Res. 2019 Mar 7:300060519830252. doi: 10.1177/0300060519830252.
    Abstract    

    Abstract available

  60. GONZALEZ-BENITEZ C, Salas P, Grabowski JP, Hernandez A, et al
    Lack of Survival Benefit of Para-Aortic Lymphadenectomy in Advanced Cervical Cancer.
    Gynecol Obstet Invest. 2019 Mar 7:1-5. doi: 10.1159/000497350.
    Abstract    

    Abstract available

  61. SCHERNBERG A, Haie-Meder C, Chargari C
    Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer.
    JAMA Oncol. 2019 Mar 7. pii: 2727346. doi: 10.1001/jamaoncol.2018.5096.
    Abstract    



  62. WANG Y, VanderWalde N, Ballo MT
    Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer-In Reply.
    JAMA Oncol. 2019 Mar 7. pii: 2727349. doi: 10.1001/jamaoncol.2019.0028.
    Abstract    



  63. YAGI A, Ueda Y, Nakagawa S, Morimoto A, et al
    Relation between the number of board-certified gynecologic oncologists per hospital and survival of cervical cancer.
    J Obstet Gynaecol Res. 2019 Mar 6. doi: 10.1111/jog.13948.
    Abstract    

    Abstract available

  64. BARR JA, Hayes KE, Brownmiller T, Harold AD, et al
    Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
    Sci Rep. 2019;9:3662.
    Abstract    

    Abstract available

  65. TAMBURRINI D, Antinori C, Slotman G
    Recurrent Small Bowel Obstruction Caused by Metastatic Cervical Cancer with Negative PAP Screening.
    Am Surg. 2018;84:e305-e306.
    Abstract    



  66. ZHAO J
    [Role of obstetricians and gynecologists in cervical cancer screening].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:241-246.
    Abstract    

    Abstract available

  67. GONG L, Lei Y, Tan X, Dong Y, et al
    Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.
    Biomed Pharmacother. 2019;111:1243-1248.
    Abstract    

    Abstract available

  68. HE C, Lv X, Huang C, Angeletti PC, et al
    A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis.
    Cell Rep. 2019;26:2636-2650.
    Abstract    

    Abstract available

  69. LI FH, Xiang L, Ran L, Zhou S, et al
    BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2019;23:1397-1407.
    Abstract    

    Abstract available

  70. ARA C, Inayat K, Hanif A, Afsar S, et al
    A Study Of Agreement Between Visual Inspection With Acetic Acid Of Cervix And Pap Smear For Cervical Cancer Screening.
    J Ayub Med Coll Abbottabad. 2018;30.
    Abstract    

    Abstract available

  71. ROY R, Pal D, Sur S, Mandal S, et al
    Pongapin and Karanjin, furanoflavanoids of Pongamia pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by differential reactive oxygen species modulation, DNA damage, and nuclear factor kappa-light-chain-enhancer of activated B cell si
    Phytother Res. 2019 Mar 5. doi: 10.1002/ptr.6302.
    Abstract    

    Abstract available

  72. WANG WJ, Li Y, Zhu J, Gao MJ, et al
    Prognostic Values of Systemic Inflammation Response (SIR) Parameters in Resectable Cervical Cancer.
    Dose Response. 2019;17:1559325819829543.
    Abstract    

    Abstract available

  73. WANG JY, Chen LJ
    The role of microRNAs in the invasion and metastasis of cervical cancer.
    Biosci Rep. 2019 Mar 4. pii: BSR20181377. doi: 10.1042/BSR20181377.
    Abstract    

    Abstract available

  74. ZHANG L, Liu SK, Song L, Yao HR, et al
    SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.
    Artif Cells Nanomed Biotechnol. 2019;47:556-564.
    Abstract    

    Abstract available

  75. THOMPSON B, Barrington WE, Briant KJ, Kupay E, et al
    Educating Latinas about cervical cancer and HPV: a pilot randomized study.
    Cancer Causes Control. 2019 Mar 4. pii: 10.1007/s10552-019-01150.
    Abstract    

    Abstract available

  76. AIERKEN K, Dong Z, Abulimiti T, Zhang Y, et al
    CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.
    Mol Genet Genomic Med. 2019 Mar 4:e626. doi: 10.1002.
    Abstract    

    Abstract available

  77. MOHANTY SK, Chopra S, Mudaliar A, Kannan S, et al
    A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer.
    Indian J Cancer. 2018;55:327-335.
    Abstract    

    Abstract available

  78. DEVARAPALLI P, Labani S, Nagarjuna N, Panchal P, et al
    Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review.
    Indian J Cancer. 2018;55:318-326.
    Abstract    

    Abstract available

  79. SHEN W, Huang Y, Zhou Y, Chang B, et al
    Intestinal metastasis after total laparoscopic radical trachelectomy for stage IB1 cervical cancer: A case report.
    Gynecol Oncol Rep. 2019;28:37-40.
    Abstract    

    Abstract available

  80. JURGENLIEMK-SCHULZ IM, Beriwal S, de Leeuw AAC, Lindegaard JC, et al
    Management of Nodal Disease in Advanced Cervical Cancer.
    Semin Radiat Oncol. 2019;29:158-165.
    Abstract    

    Abstract available

  81. WANG Y, Li G
    PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives.
    Front Med. 2019 Mar 2. pii: 10.1007/s11684-018-0674.
    Abstract    

    Abstract available

  82. ZOU C, Fan J, He M, Xu Y, et al
    Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
    Exp Cell Res. 2019 Feb 28. pii: S0014-4827(18)30776.
    Abstract    

    Abstract available

  83. ZHANG Y, Li T, Zhang L, Shangguan F, et al
    Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1alpha and protein disulfide isomerase suppresses the progression of cervical cancer.
    EBioMedicine. 2019 Feb 27. pii: S2352-3964(19)30119.
    Abstract    

    Abstract available

  84. AYDINLIK S, Dere E, Ulukaya E
    Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
    Biochim Biophys Acta Gen Subj. 2019;1863:903-916.
    Abstract    

    Abstract available

  85. HUANG H, Liu Q, Zhu L, Zhang Y, et al
    Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer.
    Sci Rep. 2019;9:3284.
    Abstract    

    Abstract available

  86. MARI R, Lambaudie E, Provansal M, Sabatier R, et al
    [Circulating tumor DNA assessment for gynaecological cancers management].
    Bull Cancer. 2019;106:237-252.
    Abstract    

    Abstract available

  87. CHEN F, Yang D, Shen H, Deng M, et al
    Hydrothermal synthesis of novel rhombic dodecahedral SnS nanocrystals for highly efficient photothermal therapy.
    Chem Commun (Camb). 2019;55:2789-2792.
    Abstract    

    Abstract available

  88. YIN X, Zhu L, Tan W, Zhu X, et al
    Time Intervals Between Prior Cervical Conization and Posterior Hysterectomy Influence Postoperative Infection in Patients with Cervical Intraepithelial Neoplasia or Cancer.
    Med Sci Monit. 2018;24:9063-9072.
    Abstract    

    Abstract available

  89. DRACHAM CB, Mahajan R, Rai B, Elangovan A, et al
    Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma.
    Jpn J Clin Oncol. 2019;49:146-152.
    Abstract    

    Abstract available

  90. ZHOU CF, Ma J, Huang L, Yi HY, et al
    Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.
    Oncogene. 2019;38:1256-1268.
    Abstract    

    Abstract available

  91. ZHANG SK, Zhao DM, Chen HM, Guo Z, et al
    [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:941-945.
    Abstract    

    Abstract available

  92. LIU Z, Teng L, Gao L, Wang H, et al
    The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
    Biochem Biophys Res Commun. 2018;504:6-12.
    Abstract    

    Abstract available

  93. PANG Y, Mao SS, Yao R, He JY, et al
    TGF-beta induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing.
    Biofabrication. 2018;10:044102.
    Abstract    

    Abstract available

  94. VERLAAT W, Van Leeuwen RW, Novianti PW, Schuuring E, et al
    Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.
    Epigenetics. 2018;13:769-778.
    Abstract    

    Abstract available

  95. HE J, He L
    Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey.
    BMC Womens Health. 2018;18:130.
    Abstract    

    Abstract available

  96. HARKENRIDER MM, Patel R, Surucu M, Chinsky B, et al
    Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Brachytherapy. 2018;17:747-752.
    Abstract    

    Abstract available

  97. WANG D, Wang H, Li Y, Li Q, et al
    MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
    Biosci Rep. 2018;38.
    Abstract    

    Abstract available

  98. SETHI R, Kuo YC, Edraki B, Lerner D, et al
    Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.
    Brachytherapy. 2018;17:742-746.
    Abstract    

    Abstract available

  99. HUANG SQ, Zhou ZX, Zheng SL, Liu DD, et al
    Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population.
    Biosci Rep. 2018;38.
    Abstract    

    Abstract available

  100. COVAN EK
    Cancer.
    Health Care Women Int. 2018;39:505-506.
    Abstract    



  101. ENGELAERE C, Poncelet E, Durot C, Dohan A, et al
    Pelvic MRI: Is Endovaginal or Rectal Filling Needed?
    Korean J Radiol. 2018;19:397-409.
    Abstract    

    Abstract available

  102. JOINT R, Chen ZE, Cameron S
    Breast and reproductive cancers in the transgender population: a systematic review.
    BJOG. 2018;125:1505-1512.
    Abstract    

    Abstract available

  103. WILLIAMS LB, McCall A, Looney SW, Joshua T, et al
    Demographic, psychosocial, and behavioral associations with cancer screening among a homeless population.
    Public Health Nurs. 2018;35:281-290.
    Abstract    

    Abstract available

  104. LEA CS, Perez-Heydrich C, Des Marais AC, Richman AR, et al
    Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    J Womens Health (Larchmt). 2019 Mar 15. doi: 10.1089/jwh.2018.7141.
    Abstract    

    Abstract available

  105. SADOH AE, Okonkwobo C, Nwaneri DU, Ogboghodo BC, et al
    Effect of Peer Education on Knowledge of Human Papilloma Virus and Cervical Cancer among Female Adolescent Students in Benin City, Nigeria.
    Ann Glob Health. 2018;84:121-128.
    Abstract    

    Abstract available

  106. YANG H, Li SP, Chen Q, Morgan C, et al
    Barriers to cervical cancer screening among rural women in eastern China: a qualitative study.
    BMJ Open. 2019;9:e026413.
    Abstract    

    Abstract available

  107. THAKUR N, Singhal P, Mehrotra R, Bharadwaj M, et al
    Impacts of Single Nucleotide Polymorphisms in three MicroRNAs (miR-146a, miR-196a2 and miR-499) on Susceptibility to Cervical Cancer among Indian Women.
    Biosci Rep. 2019 Mar 14. pii: BSR20180723. doi: 10.1042/BSR20180723.
    Abstract    

    Abstract available

  108. ABBAS M, Srivastava K, Imran M, Banerjee M, et al
    Genetic polymorphisms in DNA repair genes and their association with cervical cancer.
    Br J Biomed Sci. 2019 Mar 14. pii: 10.1080/09674845.2019.1592884.
    Abstract    

    Abstract available

  109. SIMS LB, Curry KC, Parupalli S, Horner G, et al
    Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.
    Pharm Res. 2019;36:66.
    Abstract    

    Abstract available

  110. WANG L, Wang W, Wu Y
    MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.
    Oncol Lett. 2019;17:3418-3424.
    Abstract    

    Abstract available

  111. YANG X, Yan Z, Yang H, Ni H, et al
    Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer.
    Oncol Lett. 2019;17:3387-3391.
    Abstract    

    Abstract available

  112. CHENG Y, Yang M, Peng J
    Correlation the between the regulation of miRNA-1 in c-Met-induced EMT and cervical cancer progression.
    Oncol Lett. 2019;17:3341-3349.
    Abstract    

    Abstract available

  113. WANG Y, Zhou S, Fan K, Jiang C, et al
    MicroRNA-21 and its impact on signaling pathways in cervical cancer.
    Oncol Lett. 2019;17:3066-3070.
    Abstract    

    Abstract available

  114. CHEN P, Zhang W, Yang D, Zhang W, et al
    Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases.
    Med Sci Monit. 2019;25:1894-1902.
    Abstract    

    Abstract available

  115. KIM M, Lee H, Kiang P, Aronowitz T, et al
    HPV Vaccination and Korean American College Women: Cultural Factors, Knowledge, and Attitudes in Cervical Cancer Prevention.
    J Community Health. 2019 Mar 12. pii: 10.1007/s10900-019-00634.
    Abstract    

    Abstract available

  116. MANE SD, Kamatham AN
    Ascorbyl stearate stimulates cell death by oxidative stress-mediated apoptosis and autophagy in HeLa cervical cancer cell line in vitro.
    3 Biotech. 2019;9:115.
    Abstract    

    Abstract available

  117. SUN H, Shen K, Cao D
    Progress in immunocytochemical staining for cervical cancer screening.
    Cancer Manag Res. 2019;11:1817-1827.
    Abstract    

    Abstract available

  118. GAO D, Guo Z, Wang J, Hu G, et al
    Dicerandrol B: a natural xanthone dimer induces apoptosis in cervical cancer HeLa cells through the endoplasmic reticulum stress and mitochondrial damage.
    Onco Targets Ther. 2019;12:1185-1193.
    Abstract    

    Abstract available

  119. PENG JR, Tao SY, Wen Y, Yang X, et al
    [Cost-effectiveness analysis of cervical cancer screening strategies in urban China].
    Zhonghua Zhong Liu Za Zhi. 2019;41:154-160.
    Abstract    

    Abstract available

  120. PRUSKI D, Millert-Kalinska S, Lewek A, Kedzia W, et al
    Sensitivity and specificity of hr hPV E6/E7 mrna test in detecting cervical squamous intraepithelial lesion and cervical cancer.
    Ginekol Pol. 2019;90:66-71.
    Abstract    

    Abstract available

  121. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    Abstract    



  122. LI H, Wang J, Xu F, Wang L, et al
    By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells.
    Future Oncol. 2019 Mar 12. doi: 10.2217/fon-2018-0575.
    Abstract    

    Abstract available

  123. HE YL, Li Y, Lin CY, Qi YF, et al
    Three-dimensional turbo-spin-echo amide proton transfer-weighted mri for cervical cancer: A preliminary study.
    J Magn Reson Imaging. 2019 Mar 12. doi: 10.1002/jmri.26710.
    Abstract    

    Abstract available

  124. CHEN X, Xiong D, Ye L, Wang K, et al
    Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.
    Cancer Cell Int. 2019;19:45.
    Abstract    

    Abstract available

  125. JONSSON M, Fjeldbo CS, Holm R, Stokke T, et al
    Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer.
    Neoplasia. 2019;21:353-362.
    Abstract    

    Abstract available

  126. GAO F, Feng J, Yao H, Li Y, et al
    LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis.
    Artif Cells Nanomed Biotechnol. 2019;47:776-782.
    Abstract    

    Abstract available

  127. IFEMELUMMA CC, Anikwe CC, Okorochukwu BC, Onu FA, et al
    Cervical Cancer Screening: Assessment of Perception and Utilization of Services among Health Workers in Low Resource Setting.
    Int J Reprod Med. 2019;2019:6505482.
    Abstract    

    Abstract available

  128. DANG YZ, Li P, Li JP, Zhang Y, et al
    Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer.
    J Cancer. 2019;10:1103-1109.
    Abstract    

    Abstract available

  129. LI Z, Fan P, Deng M, Zeng C, et al
    Erratum: The roles of RUNX3 in cervical cancer cells in vitro.
    Oncol Lett. 2019;17:3035.
    Abstract    

    Abstract available

  130. GUO XC, Li L, Gao ZH, Zhou HW, et al
    The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.
    Aging (Albany NY). 2019;11:1333-1341.
    Abstract    

    Abstract available

  131. WANG S, Zhu H, Ding B, Feng X, et al
    Genetic variants in microRNAs are associated with cervical cancer risk.
    Mutagenesis. 2019 Mar 10. pii: 5372967. doi: 10.1093.
    Abstract    

    Abstract available

  132. BAE H, Go YH, Kwon T, Sung BJ, et al
    A Theoretical Model for the Cell Cycle and Drug Induced Cell Cycle Arrest of FUCCI Systems with Cell-to-Cell Variation during Mitosis.
    Pharm Res. 2019;36:57.
    Abstract    

    Abstract available

  133. MAKURIROFA L, Mangwiro P, James V, Milanzi A, et al
    Women's knowledge, attitudes and practices (KAP) relating to breast and cervical cancers in rural Zimbabwe: a cross sectional study in Mudzi District, Mashonaland East Province.
    BMC Public Health. 2019;19:109.
    Abstract    

    Abstract available

  134. HJERKIND KV, Larsen IK, Moller B, Ursin G, et al
    Cancer trends and population structure in Norway 1990-2016.
    Tidsskr Nor Laegeforen. 2018;138.
    Abstract    

    Abstract available

  135. DE ALMEIDA CHUFFA LG, Seiva FRF, Cucielo MS, Silveira HS, et al
    Mitochondrial functions and melatonin: a tour of the reproductive cancers.
    Cell Mol Life Sci. 2019;76:837-863.
    Abstract    

    Abstract available

  136. JORGENSEN L, Doshi P, Gotzsche P, Jefferson T, et al
    Challenges of independent assessment of potential harms of HPV vaccines.
    BMJ. 2018;362:k3694.
    Abstract    



  137. TRUGILO KP, Cebinelli GCM, Berti FCB, Okuyama NCM, et al
    Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.
    Med Microbiol Immunol. 2019;208:49-58.
    Abstract    

    Abstract available

  138. FERNANDES R, Potter BK, Little J
    Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada.
    BMC Womens Health. 2018;18:134.
    Abstract    

    Abstract available

  139. WOO SR, Lee HJ, Oh SJ, Kim S, et al
    Stabilization of HDAC1 via TCL1-pAKT-CHFR axis is a key element for NANOG-mediated multi-resistance and stem-like phenotype in immune-edited tumor cells.
    Biochem Biophys Res Commun. 2018;503:1812-1818.
    Abstract    

    Abstract available

  140. TAGHAVI K, Banerjee D, Mandal R, Kallner HK, et al
    Colposcopy telemedicine: live versus static swede score and accuracy in detecting CIN2+, a cross-sectional pilot study.
    BMC Womens Health. 2018;18:89.
    Abstract    

    Abstract available

  141. PRATT R, Mohamed S, Dirie W, Ahmed N, et al
    Testing a Religiously Tailored Intervention with Somali American Muslim Women and Somali American Imams to Increase Participation in Breast and Cervical Cancer Screening.
    J Immigr Minor Health. 2019 Mar 21. pii: 10.1007/s10903-019-00881.
    Abstract    

    Abstract available

  142. MAO Y, Zhang L, Li Y
    circEIF4G2 modulates the malignant features of cervical cancer via the miR218/HOXA1 pathway.
    Mol Med Rep. 2019 Mar 14. doi: 10.3892/mmr.2019.10032.
    Abstract    

    Abstract available

  143. HERNANDEZ-JUAREZ J, Vargas-Sierra O, Herrera LA, Cantu De Leon D, et al
    Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.
    Int J Oncol. 2019 Mar 14. doi: 10.3892/ijo.2019.4749.
    Abstract    

    Abstract available

  144. ZHAO D, Li PP, Wang YT, Shu T, et al
    [Comparative study of three-dimensional versus two-dimensional laparoscopic C1 radical hysterectomy for cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:173-178.
    Abstract    

    Abstract available

  145. NAHAND JS, Taghizadeh-Boroujeni S, Karimzadeh M, Borran S, et al
    microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
    J Cell Physiol. 2019 Mar 19. doi: 10.1002/jcp.28457.
    Abstract    

    Abstract available

  146. BAE YS, Chang J, Park SM
    Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
    Arch Osteoporos. 2019;14:41.
    Abstract    

    Abstract available

  147. ELEJE GU, Eke AC, Igberase GO, Igwegbe AO, et al
    Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
    Cochrane Database Syst Rev. 2019;3:CD011000.
    Abstract    

    Abstract available

  148. LI J
    Improving pregnancy outcomes in fertility preserved cervical cancer patients: big challenge after radical trachelectomy.
    J Gynecol Oncol. 2019;30:e73.
    Abstract    



  149. KANAO H, Matsuo K, Aoki Y, Tanigawa T, et al
    Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer.
    J Gynecol Oncol. 2019;30:e71.
    Abstract    

    Abstract available

  150. SHIM SH
    Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    J Gynecol Oncol. 2019;30:e69.
    Abstract    



  151. SHAH JS, Jooya ND, Woodard TL, Ramirez PT, et al
    Reproductive counseling and pregnancy outcomes after radical trachelectomy for early stage cervical cancer.
    J Gynecol Oncol. 2019;30:e45.
    Abstract    

    Abstract available

  152. ALBERT A, Allbright R, Lee A, Vijayakumar S, et al
    Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
    J Gynecol Oncol. 2019;30:e41.
    Abstract    

    Abstract available

  153. CHAMBERS LM, Vargas R, Michener CM
    Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists.
    J Gynecol Oncol. 2019;30:e35.
    Abstract    

    Abstract available

  154. BALAYA V, Lecuru F, Magaud L, Ngo C, et al
    Perioperative morbidity of radical trachelectomy with lymphadenectomy in early-stage cervical cancer: a French prospective multicentric cohort.
    J Gynecol Oncol. 2019;30:e34.
    Abstract    

    Abstract available

  155. KANG Y, Sun P, Mao X, Dong B, et al
    PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
    J Gynecol Oncol. 2019;30:e29.
    Abstract    

    Abstract available

  156. PAPATHEMELIS T, Knobloch S, Gerken M, Scharl A, et al
    Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer.
    J Cancer Res Clin Oncol. 2019 Mar 18. pii: 10.1007/s00432-019-02890.
    Abstract    

    Abstract available

  157. LIU S, Chang W, Jin Y, Feng C, et al
    The function of histone acetylation in cervical cancer development.
    Biosci Rep. 2019 Mar 18. pii: BSR20190527. doi: 10.1042/BSR20190527.
    Abstract    

    Abstract available

  158. ERIKSSON EM, Lau M, Jonsson C, Zhang C, et al
    Participation in a Swedish cervical cancer screening program among women with psychiatric diagnoses: a population-based cohort study.
    BMC Public Health. 2019;19:313.
    Abstract    

    Abstract available

  159. BARCHI F, Winter SC, Ketshogile FM, Ramogola-Masire D, et al
    Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana.
    BMC Public Health. 2019;19:318.
    Abstract    

    Abstract available

  160. ZHU L, Zhang Q, Li S, Jiang S, et al
    Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p/TGFbetaI axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells.
    Cancer Med. 2019 Mar 18. doi: 10.1002/cam4.2040.
    Abstract    

    Abstract available

  161. CAO XM
    Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
    Cancer Biomark. 2019 Feb 28. pii: CBM181225. doi: 10.3233/CBM-181225.
    Abstract    

    Abstract available

  162. KAU YC, Liu FC, Kuo CF, Huang HJ, et al
    Trend and survival outcome in Taiwan cervical cancer patients: A population-based study.
    Medicine (Baltimore). 2019;98:e14848.
    Abstract    

    Abstract available

  163. XU J, Pan Q, Ju W
    Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy.
    Anticancer Drugs. 2019 Mar 19. doi: 10.1097/CAD.0000000000000779.
    Abstract    

    Abstract available

  164. KONG Y, Zong L, Yang J, Wu M, et al
    Cervical cancer in women aged 25 years or younger: a retrospective study.
    Cancer Manag Res. 2019;11:2051-2058.
    Abstract    

    Abstract available

  165. ZHAO H, He Y, Yang SL, Zhao Q, et al
    Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis.
    Onco Targets Ther. 2019;12:1881-1891.
    Abstract    

    Abstract available

  166. GULTEKIN M, Karaca MZ, Kucukyildiz I, Dundar S, et al
    Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey.
    Papillomavirus Res. 2019;7:118-122.
    Abstract    

    Abstract available

  167. JOHNSON CA, James D, Marzan A, Armaos M, et al
    Cervical Cancer: An Overview of Pathophysiology and Management.
    Semin Oncol Nurs. 2019 Mar 13. pii: S0749-2081(19)30014.
    Abstract    

    Abstract available

  168. ORCIANI M, Caffarini M, Lazzarini R, Delli Carpini G, et al
    Mesenchymal Stem Cells from Cervix and Age: New Insights into CIN Regression Rate.
    Oxid Med Cell Longev. 2018;2018:1545784.
    Abstract    

    Abstract available

  169. NAICKER MS, Tan GC
    Heterogeneity in studies of p16 in cervical lesions in different Malaysian institutions: Time to consider collaborative study.
    Malays J Pathol. 2018;40:319-323.
    Abstract    

    Abstract available

  170. YANG M, Wang M, Li X, Xie Y, et al
    Inhibition of constructed SEC3-ES lentiviral vector to proliferation, migration of Hela cells.
    Pathol Res Pract. 2019;215:315-321.
    Abstract    

    Abstract available

  171. ARUL PONNI TR, Avinash HU, Nirmala S, Janaki MG, et al
    Optimal technique of radiotherapy for carcinoma cervix in developing countries: Dosimetric and logistic comparison.
    J Cancer Res Ther. 2018;14:1207-1213.
    Abstract    

    Abstract available

  172. GININDZA TG, Almonte M, Dlamini X, Sartorius B, et al
    Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.
    Afr J Prim Health Care Fam Med. 2018;10:e1-e7.
    Abstract    

    Abstract available

  173. DING W, Ji T, Xiong W, Li T, et al
    Realgar, a traditional Chinese medicine, induces apoptosis of HPV16-positive cervical cells through a HPV16 E7-related pathway.
    Drug Des Devel Ther. 2018;12:3459-3469.
    Abstract    

    Abstract available

  174. WANG T, Qie MR
    [Relationship of Toll Like Receptors Expression and HPV16 Infection in Cervical Squamous Cell Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2018;49:649-651.
    Abstract    

    Abstract available

  175. BAI B, Liu PZ, Du YZ, Luo YM, et al
    Automatic segmentation of cervical region in colposcopic images using K-means.
    Australas Phys Eng Sci Med. 2018;41:1077-1085.
    Abstract    

    Abstract available

  176. GUPTA K, Philipose CS, Rai S, Ramapuram J, et al
    A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
    Acta Cytol. 2019;63:50-55.
    Abstract    

    Abstract available

  177. MARQUARDT K, Ziemke P, Neumann K
    Three-Tiered versus Two-Tiered Classification of Squamous Dysplasia in Cervical Cytology: Results of a Follow-Up Study.
    Acta Cytol. 2019;63:44-49.
    Abstract    

    Abstract available

  178. HAMMER A, Kahlert J, Gravitt PE, Rositch AF, et al
    Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: a registry-based cohort study.
    Acta Obstet Gynecol Scand. 2019 Mar 13. doi: 10.1111/aogs.13608.
    Abstract    

    Abstract available

  179. UMPHRESS B, Sanchez B, Paintal A, Nayar R, et al
    Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
    Am J Surg Pathol. 2018;42:479-484.
    Abstract    

    Abstract available

  180. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
    HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
    Abstract    

    Abstract available

  181. MEZQUITA G, Muruzabal JC, Perez B, Aguirre S, et al
    Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:79-83.
    Abstract    

    Abstract available

  182. CALO C, Elliott JO, Clements A, Reid G, et al
    Cervical cancer radiation therapy compliance rates based on location of radiation therapy.
    Gynecol Oncol. 2019;152:528-532.
    Abstract    

    Abstract available

  183. VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
    Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
    Gynecol Oncol. 2019;152:465-471.
    Abstract    

    Abstract available

  184. DOO DW, Kirkland CT, Griswold LH, McGwin G, et al
    Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.
    Gynecol Oncol. 2019 Mar 6. pii: S0090-8258(19)30149.
    Abstract    

    Abstract available

  185. LEITAO MM JR
    The change in landscape after a new landmark is constructed: Radical hysterectomy for early cervical cancer and Minimally Invasive Surgery.
    Gynecol Oncol. 2019;153:1-2.
    Abstract    



  186. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    Abstract    



  187. HALEC G, Scott ME, Farhat S, Darragh TM, et al
    Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
    Int J Cancer. 2018;143:2884-2891.
    Abstract    

    Abstract available

  188. NAIR VB, Manasa VG, Sinto MS, Jayasree K, et al
    Differential Expression of MicroRNAs in Uterine Cervical Cancer and Its Implications in Carcinogenesis; An Integrative Approach.
    Int J Gynecol Cancer. 2018;28:553-562.
    Abstract    

    Abstract available

  189. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.
    Int J Gynecol Cancer. 2018;28:641-655.
    Abstract    

    Abstract available

  190. RAZ Y, Keinan-Boker L, Goren S, Soen-Grisaru G, et al
    The effect of age at immigration on cervical cancer incidence: a population-based cohort study of 1 486 438 Israeli women.
    Int J Gynecol Cancer. 2019;29:492-496.
    Abstract    

    Abstract available

  191. MABUCHI S, Yokoi E, Shimura K, Komura N, et al
    A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy.
    Int J Gynecol Cancer. 2019;29:474-479.
    Abstract    

    Abstract available

  192. GUANI B, Dorez M, Magaud L, Buenerd A, et al
    Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial.
    Int J Gynecol Cancer. 2019;29:447-452.
    Abstract    

    Abstract available

  193. LECURU FR, McCormack M, Hillemanns P, Anota A, et al
    SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study.
    Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2019-000332.
    Abstract    

    Abstract available

  194. HALASKA MJ, Uzan C, Han SN, Fruscio R, et al
    Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.
    Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103.
    Abstract    

    Abstract available

  195. CHINO J, Beriwal S
    Advanced Treatment Technique for Locally Advanced Cervical Cancer: Time for a Standard of Care Shift?
    Int J Radiat Oncol Biol Phys. 2019;103:1098-1099.
    Abstract    



  196. BO H, Fan L, Gong Z, Liu Z, et al
    Upregulation and hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7027.
    Abstract    

    Abstract available

  197. YI Y, Liu Y, Wu W, Wu K, et al
    Reconstruction and analysis of circRNAmiRNAmRNA network in the pathology of cervical cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7028.
    Abstract    

    Abstract available

  198. ZHENG M, Zhou Q, Liu X, Wang C, et al
    CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway.
    Oncol Rep. 2019;41:1531-1538.
    Abstract    

    Abstract available

  199. LI T, Li M, Xu C, Xu X, et al
    miR146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NFkappaB signaling by targeting TRAF6.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7046.
    Abstract    

    Abstract available

  200. XING D, Lu J
    Distinctive clinicopathological features and diseasespecific survival of adenoid cystic carcinoma and adenoid basal carcinoma in the lower female genital tract.
    Oncol Rep. 2019;41:1769-1778.
    Abstract    

    Abstract available

  201. ZHANG L, Zhou J, Qin X, Huang H, et al
    Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGFbeta1mediated PI3K and MAPK pathways.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7062.
    Abstract    

    Abstract available

  202. MURAKAMI N, Kobayashi K, Shima S, Tsuchida K, et al
    A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience.
    BMC Cancer. 2019;19:221.
    Abstract    

    Abstract available

  203. BU Q, Wang S, Ma J, Zhou X, et al
    The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
    BMC Cancer. 2018;18:1182.
    Abstract    

    Abstract available

  204. SILVEIRA CRF, Cipelli M, Manzine C, Rabelo-Santos SH, et al
    Swainsonine, an alpha-mannosidase inhibitor, may worsen cervical cancer progression through the increase in myeloid derived suppressor cells population.
    PLoS One. 2019;14:e0213184.
    Abstract    

    Abstract available

  205. TEAME H, Gebremariam L, Kahsay T, Berhe K, et al
    Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia, 2018; Case control study.
    PLoS One. 2019;14:e0213546.
    Abstract    

    Abstract available

  206. HSU HC, Tai YJ, Chen YL, Chiang YC, et al
    Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.
    PLoS One. 2018;13:e0204950.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;